AA Pharma Consultancy Limited - Accounts to registrar (filleted) - small 18.2

AA Pharma Consultancy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.3.4.1 07677961 director 1.7.19 30.6.20 30.6.20 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure076779612019-06-30076779612020-06-30076779612019-07-012020-06-30076779612018-06-30076779612018-07-012019-06-30076779612019-06-3007677961ns16:EnglandWales2019-07-012020-06-3007677961ns15:PoundSterling2019-07-012020-06-3007677961ns11:Director12019-07-012020-06-3007677961ns11:PrivateLimitedCompanyLtd2019-07-012020-06-3007677961ns11:SmallEntities2019-07-012020-06-3007677961ns11:AuditExemptWithAccountantsReport2019-07-012020-06-3007677961ns11:SmallCompaniesRegimeForDirectorsReport2019-07-012020-06-3007677961ns11:SmallCompaniesRegimeForAccounts2019-07-012020-06-3007677961ns11:FullAccounts2019-07-012020-06-3007677961ns11:RegisteredOffice2019-07-012020-06-3007677961ns6:CurrentFinancialInstruments2020-06-3007677961ns6:CurrentFinancialInstruments2019-06-3007677961ns6:ShareCapital2020-06-3007677961ns6:ShareCapital2019-06-3007677961ns6:RetainedEarningsAccumulatedLosses2020-06-3007677961ns6:RetainedEarningsAccumulatedLosses2019-06-30
REGISTERED NUMBER: 07677961 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2020

FOR

AA PHARMA CONSULTANCY LIMITED

AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Report of the Accountants 4

AA PHARMA CONSULTANCY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2020







DIRECTOR: Miss M F Jones





REGISTERED OFFICE: The Old Post Office
Nuffield
Henley- on-Thames
Oxfordshire
RG9 5SS





REGISTERED NUMBER: 07677961 (England and Wales)





ACCOUNTANTS: Claritas Accountancy Limited
1 Peach Street
Wokingham
Berkshire
RG40 1XJ

AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)

BALANCE SHEET
30 JUNE 2020

30.6.20 30.6.19
Notes £    £   
CURRENT ASSETS
Debtors 4 1,950 1,950

CREDITORS
Amounts falling due within one year 5 1,546 1,546
NET CURRENT ASSETS 404 404
TOTAL ASSETS LESS CURRENT
LIABILITIES

404

404

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 403 403
SHAREHOLDERS' FUNDS 404 404

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 May 2021 and were signed by:





Miss M F Jones - Director


AA PHARMA CONSULTANCY LIMITED (REGISTERED NUMBER: 07677961)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020

1. STATUTORY INFORMATION

AA Pharma Consultancy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2019 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.20 30.6.19
£    £   
Other debtors 1,950 1,950

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.20 30.6.19
£    £   
Bank loans and overdrafts 10 10
Directors' current accounts 1,536 1,536
1,546 1,546

AA PHARMA CONSULTANCY LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
AA PHARMA CONSULTANCY LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

Report of the accountant to the directors of AA Pharma Consultancy Limited.

These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 30 June 2020.

We have prepared these finance statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.

On the balance sheet you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give "a true and fair view".

You have determined that the company is exempt from the statutory requirement for an audit for this accounting year ended 30 June 2020. Therefore, the financial statements are unaudited.

The financial statements are provided exclusively to the directors for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.






Claritas Accountancy Limited
1 Peach Street
Wokingham
Berkshire
RG40 1XJ


20 May 2021